Center For Scientific Review; Notice of Closed Meetings, 12858-12859 [2012-5046]
Download as PDF
12858
Federal Register / Vol. 77, No. 42 / Friday, March 2, 2012 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 USC,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel NIDA–
K Special Emphasis Panel (SEP).
Date: March 6, 2012.
Time: 4:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Nadine Rogers, Ph.D.,
Scientific Review Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Blvd., Room 4229, MSC 9550, Bethesda, MD
20892–9550, 301–402–2105,
rogersn2@nida.nih.gov
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel,
Collaborative Clinical Trials in Drug Abuse.
Date: March 13, 2012.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Gerald L. McLaughlin,
Ph.D., Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Blvd., Room 4238, MSC 9550, Bethesda, MD
20892–9550, 301–402–6626,
gm145a@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel,
Multisite Medications Development for
SUDs.
Date: March 15, 2012.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
VerDate Mar<15>2010
17:01 Mar 01, 2012
Jkt 226001
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Gerald L. McLaughlin,
Ph.D., Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Blvd., Room 4238, MSC 9550, Bethesda, MD
20892–9550, 301–402–6626,
gm145a@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, 2012
Translational Avant Garde Review (DP1).
Date: March 27, 2012.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn, 7301 Waverly
Street, Bethesda, MD 20814.
Contact Person: Scott A. Chen, Ph.D.,
Scientific Review Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 4234, MSC
9550, 6001 Executive Blvd., Bethesda, MD
20892–9550, 301–443–9511,
chensc@mail.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, DIDARP
Review.
Date: March 30, 2012.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Nadine Rogers, Ph.D.,
Scientific Review Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Blvd., Room 4229, MSC 9550, Bethesda, MD
20892–9550, 301–402–2105,
rogersn2@nida.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: February 24, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–5039 Filed 3–1–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Cell Biology.
Date: March 21–22, 2012.
Time: 8 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Wallace Ip, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5128,
MSC 7840, Bethesda, MD 20892, 301–435–
1191, ipws@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, RFA Panel:
CounterAct U54 Cooperative Agreements.
Date: March 22, 2012.
Time: 8 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Monaco Alexandria, 480 King
Street, Alexandria, VA 22314.
Contact Person: Jonathan K Ivins, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040A,
MSC 7806, Bethesda, MD 20892, (301) 594–
1245, ivinsj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Fellowship:
Oncological Sciences.
Date: March 22–27, 2012.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Ross D Shonat, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5156,
MSC 7849, Bethesda, MD 20892, 301–435–
2786, shonatr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, RFA Panel:
CounterAct U01 Cooperative Agreements.
Date: March 23, 2012.
Time: 8 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Monaco Alexandria, 480 King
Street, Alexandria, VA 22314.
Contact Person: Jonathan K Ivins, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040A,
MSC 7806, Bethesda, MD 20892, (301) 594–
1245, ivinsj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, RFA MH12–
080: Advancing HIV Prevention through
Transformative Behavioral and Social
Science Research.
Date: March 23, 2012.
E:\FR\FM\02MRN1.SGM
02MRN1
Federal Register / Vol. 77, No. 42 / Friday, March 2, 2012 / Notices
Time: 10 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Jose H Guerrier, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–435–
1137, guerriej@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business: Digestive Sciences.
Date: March 26, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Bonnie L. Burgess-Beusse,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182,
MSC 7818, Bethesda, MD 20892, 301–435–
1783, beusseb@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Pilot and
Feasibility Clinical Research Studies in
Digestive Diseases and Nurtrition
Date: March 26, 2012.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Peter J Perrin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180,
MSC 7818, Bethesda, MD 20892, (301) 435–
0682, perrinp@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
National Institute of Neurological
Disorders and Stroke Notice of
Meeting
The meeting will feature invited
speakers and discussion of committee
business items including a report on the
findings of the Institute of Medicine
report Relieving Pain in America: A
Blueprint for Transforming Prevention,
Care, Education, and Research and a
review of information gathered on
federally-funded pain research.
The meeting will be open to the
public and accessible by live webcast
and conference call.
Name of Committee: Interagency Pain
Research Coordinating Committee.
Type of meeting: Open Meeting.
Date: March 27, 2012.
Time: 8:30 a.m. to 4:30 p.m. *Eastern
Time*—Approximate end time.
Agenda: The meeting will feature
invited speakers and discussion of
committee business items including a
report on the findings of the Institute of
Medicine report Relieving Pain in
America: A Blueprint for Transforming
Prevention, Care, Education, and
Research and a review of information
gathered on federally-funded pain
research.
Place: National Institutes of Health,
Building 1, Wilson Hall, 1 Center Drive,
Bethesda, MD 20892.
Conference Call: Dial: 800–779–1482,
Participant Passcode: 31855.
Cost: The meeting is free and open to
the public.
Webcast Live https://videocast.nih.
gov/.
Registration: https://iprcc.nih.gov/.
Pre-registration is recommended to
expedite check-in. Seating in the
meeting room is limited to room
capacity and is on a first come, first
served basis.
Deadlines: Notification of intent to
present oral comments: Friday, March
16, 2012, by 5 p.m. ET
Submission of written/electronic
statement for oral comments: Tuesday,
March 20, 2012, by 5 p.m. ET
Submission of written comments:
Thursday, March 22, 2012, by 5 p.m. ET
Access: Medical Center Metro (Red
Line) Visitor Information: https://
www.nih.gov/about/visitor/index.htm.
Contact Person: Dr. Paul Scott,
Director, Office of Science Policy and
Planning, National Institute of
Neurological Disorders and Stroke, NIH,
31 Center Drive, Room 8A03, Bethesda,
MD 20892, Phone: (301) 496–9271,
Email: IPRCC
PublicInquiries@mail.nih.gov.
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of an Interagency Pain
Research Coordinating Committee
(IPRCC) meeting.
Please Note: Any member of the public
interested in presenting oral comments to the
Committee must notify the Contact Person
listed on this notice by 5 p.m. ET on Friday,
March 16, 2012, with their request to present
oral comments at the meeting. Interested
individuals and representatives of
Dated: February 24, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–5046 Filed 3–1–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
tkelley on DSK3SPTVN1PROD with NOTICES
National Institutes of Health
VerDate Mar<15>2010
18:58 Mar 01, 2012
Jkt 226001
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
12859
organizations must submit a written/
electronic copy of the oral statement/
comments including a brief description of the
organization represented by 5 p.m. ET on
Tuesday, March 20, 2012.
Statements submitted will become a
part of the public record. Only one
representative of an organization will be
allowed to present oral comments on
behalf of that organization, and
presentations will be limited to three to
five minutes per speaker, depending on
number of speakers to be accommodated
within the allotted time. Speakers will
be assigned a time to speak in the order
of the date and time when their request
to speak is received, along with the
required submission of the written/
electronic statement by the specified
deadline. If special accommodations are
needed, please email the Contact Person
listed above.
In addition, any interested person
may submit written comments to the
IPRCC prior to the meeting by sending
the comments to the Contact Person
listed on this notice by 5 p.m. ET,
Thursday, March 22, 2012. The
comments should include the name
and, when applicable, the business or
professional affiliation of the interested
person. All written comments received
by the deadlines for both oral and
written public comments will be
provided to the IPRCC for their
consideration and will become part of
the public record. The meeting will be
open to the public through a conference
call phone number and webcast live on
the Internet. Members of the public who
participate using the conference call
phone number will be able to listen to
the meeting but will not be heard. If you
experience any technical problems with
the conference call or webcast, please
call Operator Service on 301 496–4517
for conference call issues and the NIH
IT Service Desk at (301) 496–4357, toll
free (866) 319–4357, for webcast issues.
Individuals who participate in person
or by using these electronic services and
who need special assistance, such as
captioning of the conference call or
other reasonable accommodations,
should submit a request to the Contact
Person listed on this notice at least
seven days prior to the meeting.
As a part of security procedures,
attendees should be prepared to present
a photo ID during the security process
to get on the NIH campus. For a full
description, please see: https://
www.nih.gov/about/visitorsecurity.htm.
Pre-registration is recommended.
Seating will be limited to the room
capacity and seats will be on a first
come, first served basis, with expedited
check-in for those who are preregistered.
E:\FR\FM\02MRN1.SGM
02MRN1
Agencies
[Federal Register Volume 77, Number 42 (Friday, March 2, 2012)]
[Notices]
[Pages 12858-12859]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-5046]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflict: Cell Biology.
Date: March 21-22, 2012.
Time: 8 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Wallace Ip, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5128, MSC 7840, Bethesda, MD 20892, 301-435-
1191, ipws@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, RFA Panel: CounterAct U54 Cooperative Agreements.
Date: March 22, 2012.
Time: 8 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Monaco Alexandria, 480 King Street, Alexandria, VA
22314.
Contact Person: Jonathan K Ivins, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040A, MSC 7806, Bethesda, MD
20892, (301) 594-1245, ivinsj@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Fellowship: Oncological Sciences.
Date: March 22-27, 2012.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Ross D Shonat, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5156, MSC 7849, Bethesda, MD 20892, 301-435-
2786, shonatr@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, RFA Panel: CounterAct U01 Cooperative Agreements.
Date: March 23, 2012.
Time: 8 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Monaco Alexandria, 480 King Street, Alexandria, VA
22314.
Contact Person: Jonathan K Ivins, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040A, MSC 7806, Bethesda, MD
20892, (301) 594-1245, ivinsj@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, RFA MH12-080: Advancing HIV Prevention through Transformative
Behavioral and Social Science Research.
Date: March 23, 2012.
[[Page 12859]]
Time: 10 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jose H Guerrier, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD
20892, 301-435-1137, guerriej@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Small Business: Digestive Sciences.
Date: March 26, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Bonnie L. Burgess-Beusse, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182, MSC 7818, Bethesda, MD
20892, 301-435-1783, beusseb@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Pilot and Feasibility Clinical Research Studies in Digestive
Diseases and Nurtrition
Date: March 26, 2012.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Peter J Perrin, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180, MSC 7818, Bethesda, MD
20892, (301) 435-0682, perrinp@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: February 24, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-5046 Filed 3-1-12; 8:45 am]
BILLING CODE 4140-01-P